NCT01869556View on ClinicalTrials.gov

Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

June 4, 2013

Primary Completion Date

July 8, 2019

Study Completion Date

September 30, 2019

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Oxytocin

Oxytocin 5IU IV bolus, followed by an infusion of oxytocin 20IU/L, running at at rate of 40mIU/min for 8 hours

DRUG

Ergot

Ergot 0.25mg IV

DRUG

Carboprost

Carboprost 0.25mg IM

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT01869556 - Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress | Biotech Hunter | Biotech Hunter